Core Viewpoint - Rogers Sugar Inc. announced a public offering of $50,000,000 aggregate principal amount of Ninth Series convertible unsecured subordinated debentures with an annual interest rate of 5.50% and a maturity date of January 31, 2033 [1][2]. Group 1: Offering Details - The offering price for the Offered Debentures is set at $1,000 per debenture [1]. - The Offered Debentures will be convertible into common shares at a conversion price of $7.91 per share [2]. - The Offered Debentures are not redeemable prior to January 31, 2029, and can be redeemed under specific conditions thereafter [2]. Group 2: Underwriters and Over-Allotment Option - The offering is being conducted through a syndicate of underwriters co-led by BMO Capital Markets and National Bank Capital Markets [2]. - An Over-Allotment Option allows underwriters to purchase up to an additional $7,500,000 of Offered Debentures within 30 days after the closing of the offering [3]. Group 3: Use of Proceeds - The net proceeds from the offering will be used to reduce outstanding amounts under the credit facility of Lantic Inc., a subsidiary of Rogers Sugar, and for general corporate purposes [4]. Group 4: Regulatory and Filing Information - The Offered Debentures will be offered in Canada pursuant to a prospectus supplement that will be filed by January 7, 2026 [6]. - The offering is expected to close on or about January 12, 2026, subject to regulatory and TSX approval [4].

Core Viewpoint - Hydreight Technologies Inc. has announced a private placement offering of up to C$10,000,000 in unsecured convertible debentures to support its digital healthcare solutions business [1][6] Group 1: Offering Details - The company has granted Canaccord Genuity Corp. an option to increase the offering size by up to C$1,500,000 [2] - The debentures will mature 36 months from issuance and are convertible into common shares at a price of C$4.06 per share [3] - The offering is expected to close around September 4, 2025, pending regulatory approvals [6] Group 2: Financial Terms - The debentures will bear a fixed interest rate of 9.0% per annum, payable semi-annually [5] - The company will pay a cash commission of 6.0% to the lead agent and issue compensation warrants equal to 6.0% of the number of shares issuable upon conversion [7] Group 3: Company Overview - Hydreight Technologies Inc. is building a large mobile clinic network in the U.S., with over 2,500 nurses and 100 doctors across 50 states [10] - The company's platform includes integrated tools for healthcare professionals to provide services directly to patients [10]